REQUEST A DEMO
Total
USD $0.00
Search more companies

Psomagen, Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Psomagen, Inc. Profile Updated: July 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Psomagen, Inc. is an enterprise based in South Korea. Its main office is in Wilmington. The enterprise currently operates in the Research and Development in Nanotechnology sector. It was first established on April 19, 2026. It currently has a total number of 93 (2024) employees. From the latest financial highlights, Psomagen, Inc. reported a net sales revenue increase of 35.33% in 2024. Its’ total assets recorded a growth of 24.36%. The enterprise’s net profit margin decreased by 0.66% in 2024.

Headquarters
State Of Delaware
Wilmington; Delaware;

Contact Details: Purchase the Psomagen, Inc. report to view the information.

Website: http://psomagen.com

Basic Information
Total Employees:
Purchase the Psomagen, Inc. report to view the information.
Outstanding Shares:
Purchase the Psomagen, Inc. report to view the information.
Registered Capital:
Purchase the Psomagen, Inc. report to view the information.
Financial Auditors:
Purchase the Psomagen, Inc. report to view the information.
Incorporation Date:
April 19, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
주식회사 마크로젠
Company Performance
Financial values in the chart are available after Psomagen, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
35.33%
Total Operating Revenue
35.58%
Operating Profit
-40.37%
EBITDA
N/A
Net Profit/Loss for the Period
-41.88%
Total Assets
24.36%
Total Equity
-6.04%
Operating Profit Margin
-0.51%
Net Profit Margin
-0.66%
Return on Equity (ROE)
-8.72%
Debt / Equity
21.88%
Quick Ratio
-0.78%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?